MedTrace Logo

Big Data Analysis of the Use of bIomarkers Concentration

NCT03254472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 585745

Last updated 2017-08-22

No results posted yet for this study

Summary

The investigators conducted a retrospective analysis of all measured concentrations performed in a large subset of laboratories located in the French Brittany from February 2010 the 17th to August 2015 the 30th, in adults over 20 years old.

The investigators are aimed at studying physicians' use and eventually misuse of biomarkers dosage and the characteristics of a broad population based on some biomarkers concentrations.

Conditions

  • Biological Markers
  • Inappropriate Prescribing

Interventions

DIAGNOSTIC_TEST

Measured concentrations of biomarkers

Sponsors & Collaborators

  • Roche Diagnostics GmbH

    collaborator INDUSTRY

  • ProBayes

    collaborator UNKNOWN

  • Biorance Laboratoires Réunis

    collaborator UNKNOWN

  • Hospital Avicenne

    lead OTHER

Principal Investigators

  • Christophe Meune, MD PhD · Avicenne Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-17
Primary Completion
2015-08-30
Completion
2015-09-10

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03254472 on ClinicalTrials.gov